Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc. focuses on conditions linked to impaired body weight and hunger control, with research centered on obesity driven by specific genetic variants affecting melanocortin pathway signaling.

• Setmelanotide in genetically defined obesity
• Body weight change
• Hunger regulation

The sponsor’s clinical activity is directed toward precision medicine approaches for patients whose obesity is associated with disrupted biological pathways controlling appetite and energy balance.